Solventum Corporation (SOLV)
NYSE: SOLV · Surgical & Medical Instruments & Apparatus · St. Paul, MN · filing with the SEC since 2023
Income statement, as filed
In millions of US dollars (USD), as filed; per-share figures in US dollars; share counts in millions. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
| Report filed | Feb 27, 2026 | Feb 28, 2025 | · | · |
| Revenue | 8,325 | 8,254 | 8,197 | 8,130 |
| Gross profit | 4,451 | 4,593 | 4,693 | 4,695 |
| Research and development | 739 | 775 | 758 | 767 |
| Selling, general and administrative | 3,080 | 2,782 | 2,299r | 2,235 |
| Operating income | 2,181 | 1,036 | 1,692 | 1,693 |
| Interest income (expense), net | -347 | -367 | 0 | 0 |
| Other income (expense), net | -39 | -64 | -25 | -1 |
| Income before income taxes | 1,713 | 605 | 1,667 | 1,692 |
| Income tax expense | 157 | 127 | 321 | 349 |
| Net income | 1,556 | 479 | 1,346 | 1,343 |
| Earnings per share, basic | 8.94 | 2.77 | 7.79 | 7.78 |
| Earnings per share, diluted | 8.88 | 2.76 | 7.79 | 7.78 |
| Weighted average shares, basic | 174.1 | 173.2 | 172.7 | 172.7 |
| Weighted average shares, diluted | 175.3 | 173.7 | 172.7 | 172.7 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenuesGross profit revenue less the cost of what it sold
us-gaap:GrossProfitResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSelling, general and administrative the cost of selling and of running the company
us-gaap:SellingGeneralAndAdministrativeExpenseOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest income (expense), net interest earned less interest paid, outside the business
us-gaap:InterestIncomeExpenseNonoperatingNetOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding